Showing results (1911-1920 of 1,955) with videos related to

Sort By:
Pageof 196
Plos One|March 21, 2024
COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants Omicron BA.1, BA.2, BA.4/5 or Delta associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination historyHermaleigh Townsley, Joshua Gahir, Timothy W Russell, et al.
Stem Cells and Development|December 6, 2013
The implementation of novel collaborative structures for the identification and resolution of barriers to pluripotent stem cell translationDavid A Brindley, Anna French, Jane Suh, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|July 27, 2010
A summary report of the COLIPA international validation study on alternatives to the draize rabbit eye irritation testP G Brantom, L H Bruner, M Chamberlain, et al.
Annals of Surgical Oncology|June 28, 2023
Changes in Surgical Management of the Axilla Over 11 Years - Report on More Than 1500 Breast Cancer Patients Treated with Neoadjuvant Chemotherapy on the Prospective I-SPY2 TrialJudy C Boughey, Hongmei Yu, Catherine Lu Dugan, et al.
Nature Communications|January 25, 2020
The Medical Genome Reference Bank contains whole genome and phenotype data of 2570 healthy elderlyMark Pinese, Paul Lacaze, Emma M Rath, et al.
The Lancet. Infectious Diseases|September 14, 2024
Real-time estimation of immunological responses against emerging SARS-CoV-2 variants in the UK: a mathematical modelling studyTimothy W Russell, Hermaleigh Townsley, Joel Hellewell, et al.
The Lancet. Rheumatology|May 11, 2024
Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trialCarl S Goodyear, Amit Patel, Eleanor Barnes, et al.
Journal for Immunotherapy of Cancer|August 24, 2022
Outcomes with adjuvant anti-PD-1 therapy in patients with sentinel lymph node-positive melanoma without completion lymph node dissectionZeynep Eroglu, Kristy K Broman, John F Thompson, et al.
Journal of the American College of Surgeons|December 14, 2020
Surveillance of Sentinel Node-Positive Melanoma Patients with Reasons for Exclusion from MSLT-II: Multi-Institutional Propensity Score Matched AnalysisKristy K Broman, Tasha M Hughes, Lesly A Dossett, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 2022
The efficacy of immune checkpoint blockade for melanoma in-transit with or without nodal metastases - A multicenter cohort studyCarl-Jacob Holmberg, Lars Ny, Tina J Hieken, et al.
Pageof 196